These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 3752937)
1. Early changes accompanying development of adriamycin resistance in spheroids of a mouse mammary carcinoma line. Vasanthi LG; Bakanauskas VJ; Conger AD Anticancer Res; 1986; 6(4):567-72. PubMed ID: 3752937 [TBL] [Abstract][Full Text] [Related]
2. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells. Ganapathi R; Reiter W; Krishan A J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267 [TBL] [Abstract][Full Text] [Related]
3. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin. Kawanami K; Nakamura T; Ono M; Kusano T; Okada K; Kikuchi A; Adachi N; Kohno K; Higashi K; Kuwano M Oncol Res; 1996; 8(5):197-206. PubMed ID: 8884812 [TBL] [Abstract][Full Text] [Related]
4. [Macrophage-mediated induction of drug-resistance variants in a mouse mammary tumor cell line]. Yamashina K Hokkaido Igaku Zasshi; 1986 Jul; 61(4):568-75. PubMed ID: 3758918 [TBL] [Abstract][Full Text] [Related]
5. [Reversal of adriamycin resistance by verapamil and ligustrazini in mouse Ehrlich ascites cancer]. Hu YP; Lin J; Wang QD; Yie QX; Zhang TM Yao Xue Xue Bao; 1993; 28(1):75-8. PubMed ID: 8328276 [TBL] [Abstract][Full Text] [Related]
6. [The correlation between multidrug resistance and glutathione (GSH) in EAC, EAC/ADR and EAC/ADR(R) cell lines]. Wang QD; Li GD; Liu MJ; Zhang Y; Liu J; Zhang TM Yao Xue Xue Bao; 1994; 29(1):20-3. PubMed ID: 8036896 [TBL] [Abstract][Full Text] [Related]
7. [The G and C banding chromosome patterns of the transplantable mammary adenocarcinoma in mice]. Ling LH Zhonghua Zhong Liu Za Zhi; 1985 Nov; 7(6):423-5. PubMed ID: 3869923 [TBL] [Abstract][Full Text] [Related]
8. Karyotypes of the 5-azacytidine-sensitive and -resistant line of AKR mouse leukemia. Seifertová M Neoplasma; 1981; 28(3):317-23. PubMed ID: 6170003 [TBL] [Abstract][Full Text] [Related]
9. Allelotypic and cytogenetic characterization of chemically induced mouse mammary tumors: high frequency of chromosome 4 loss of heterozygosity at advanced stages of progression. Aldaz CM; Liao QY; Paladugu A; Rehm S; Wang H Mol Carcinog; 1996 Nov; 17(3):126-33. PubMed ID: 8944072 [TBL] [Abstract][Full Text] [Related]
10. Chromosomal changes associated with resistance to doxorubicin: correlation with tumorigenicity. Tapiero H; Patet J; Fourcade A; Huppert J Anticancer Res; 1986; 6(2):203-8. PubMed ID: 3707056 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine. Ganapathi R; Grabowski D Cancer Res; 1983 Aug; 43(8):3696-9. PubMed ID: 6861140 [TBL] [Abstract][Full Text] [Related]
12. [Type A adenocarcinoma grafted into C3H/he mice subjected to treatment with various antineoplastic agents. II. Histopathological and ultrastructural study]. Flores JM; Gallego E; Castaño M; González JL Rev Esp Oncol; 1983; 30(3):361-78. PubMed ID: 6571378 [TBL] [Abstract][Full Text] [Related]
13. Chromosomal modifications of a rat glioblastoma cell line during the acquisition and reversal of doxorubicin resistance. Montaudon D; Benchekroun MN; Londos-Gagliardi D; Robert J Anticancer Res; 1990; 10(6):1667-75. PubMed ID: 2285241 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids, and xenografts in immune-deprived mice. Erlichman C; Vidgen D Cancer Res; 1984 Nov; 44(11):5369-75. PubMed ID: 6488191 [TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human and mouse breast cancer cells. Asano T; Kleinerman ES; Zwelling LA; Zhou Z; Fukunaga Y Acta Oncol; 2005; 44(3):240-7. PubMed ID: 16076696 [TBL] [Abstract][Full Text] [Related]
16. Increased epidermal growth factor receptor in an estrogen-responsive, adriamycin-resistant MCF-7 cell line. Dickstein B; Valverius EM; Wosikowski K; Saceda M; Pearson JW; Martin MB; Bates SE J Cell Physiol; 1993 Oct; 157(1):110-8. PubMed ID: 8408230 [TBL] [Abstract][Full Text] [Related]
17. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model. Plum SM; Hanson AD; Volker KM; Vu HA; Sim BK; Fogler WE; Fortier AH Clin Cancer Res; 2003 Oct; 9(12):4619-26. PubMed ID: 14555538 [TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain. Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317 [TBL] [Abstract][Full Text] [Related]
19. High-level, unstable adriamycin resistance in a Chinese hamster mutant cell line with double minute chromosomes. Howell N; Belli TA; Zaczkiewicz LT; Belli JA Cancer Res; 1984 Sep; 44(9):4023-9. PubMed ID: 6744317 [TBL] [Abstract][Full Text] [Related]
20. The response of EMT6 tumor spheroids to combined treatment with misonidazole and either nitrogen mustard, adriamycin, or BCNU. Twentyman PR Cancer Clin Trials; 1980; 3(3):253-6. PubMed ID: 7438322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]